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Abstract: Cocaine addiction is characterized by a persistently heightened
susceptibility to drug relapse. For this reason, the identification of medications
that prevent drug relapse is a critical goal of drug abuse research. Drug reexposure, the onset of stressful life events, and exposure to cues previously
associated with drug use have been identified as determinants of relapse in
humans and have been found to reinstate extinguished cocaine seeking in
rats. This study examined the effects of acute oral (gavage) administration of
levo-tetrahydropalmatine (l-THP), a tetrahydroprotoberberine isoquinoline
with a pharmacological profile that includes antagonism of D1, D2 and D3
dopamine receptors, on the reinstatement of extinguished cocaine seeking by
a cocaine challenge (10 mg/kg, ip), a stressor (uncontrollable electric
footshock [EFS]) or response-contingent exposure to a stimulus (tone and
light complex) previously associated with drug delivery in male SpragueDawley rats. Extinguished drug seeking was reinstated by ip cocaine, EFS, or
response-contingent presentation of drug-associated cues in vehiclepretreated rats following extinction of iv cocaine self-adminisration. Oral
administration of either 3.0 or 10.0 mg/kg l-THP one hour prior to
reinstatement testing significantly attenuated reinstatement by each of the
stimuli. Food-reinforced responding and baseline post-extinction responding
were significantly attenuated at the 10.0, but not the 3.0 mg/kg, l-THP dose,
indicating that the effects of 3 mg/kg l-THP on reinstatement were likely
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independent of non-specific motor impairment. These findings further suggest
that l-THP may have utility for the treatment of cocaine addiction.
Keywords: relapse, dopamine, THP, craving, cocaine, reinstatement

1. Introduction
The unpredictable relapse of drug use that occurs even after
extended periods of drug abstinence is the primary obstacle to the
effective management of cocaine addiction. Although a number of
factors likely contribute to relapse, drug re-exposure, the onset of
stressful life events, and exposure to cues previously associated with
drug self-administration are among the most important determinants
of drug use. Relapse precipitated by each of these stimuli can be
studied in rats using the self-administration/reinstatement approach
(de Wit and Stewart, 1981; Erb et al., 1996; Meil and See, 1996;
Ahmed and Koob, 1997).
Although a number of potentially promising medications have
been identified for treating drug-dependent individuals (Vocci et al.,
2005), a demand exists for new and more effective medicinal
approaches, particularly those that target drug craving and relapse
(O’Brien, 2005). Despite their potential efficacy, traditional herbal
preparations are often not considered to be viable options for treating
drug addiction, due in part to the limited number of reliable clinical
and preclinical studies examining their utility. However, there has been
a recent effort by many to test the effectiveness of such agents and
their active constituents using accepted preclinical disease models and
well-controlled clinical trials (Ernst, 2005; Lu et al., 2009).
Tetrahydropalmatine (THP) is a tetrahydroprotoberberine
(THPB) isoquinoline alkaloid and a primary active constituent of herbal
preparations containing plant species of the genera Stephania
(Menispermaceae family) and Corydalis (Fumariaceae family),
including Bin Ju Huan, Yan Hu Suo, Di Bu Long and Hua Jian Jiu Teng.
Two of these species, Corydalis ambigua (yan hu suo) and Stephania
tetranda (fang ji) are among the 50 fundamental herbs in Chinese
herbology and have been used traditionally for their sedative,
neuroleptic and analgesic properties (Ding, 1987). In particular, the
levo isomer of THP (l-THP) appears to contribute to many of the
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therapeutic effects of these preparations, presumably through its
interactions with dopamine (DA) receptors (Jin, 1987; Chu et al.,
2008).
A large body of data, including our own preliminary analyses,
indicates that l-THP is an antagonist at DA D1 and D2 receptors (D1R,
D2R; Jin, 1987; Guo et al., 1997; Mantsch et al., 2007; Huang and
Jin, 1992; Hu and Jin, 1999; Jin et al., 1986; Sun et al., 1992; Wu et
al., 1990; Xu et al., 1989; Zhu et al., 1991). Considering the
involvement of dopaminergic neurotransmission in drug addiction and
relapse (Volkow et al., 2004; Anderson and Pierce, 2005), compounds
such as l-THP which antagonize DA receptors have long been thought
to represent potential medications for the management of cocaine
addiction. However, despite its promise, this approach has been
largely unsuccessful due to lack of efficacy and/or the occurrence of
use limiting side effects, attributable in part to undesirable
pharmacological profiles that include high affinity antagonism of D2R
(Platt et al., 2002). Compared to many other DA receptor antagonist
drugs, l-THP has lower affinity for D2R relative to D1R (Jin, 1987). lTHP also binds to D3 DA receptors (Mantsch et al., 2007), likely
functioning as an antagonist, and has secondary actions at a number
of non-DA receptors (Lu et al., 1996; Halbsguth et al., 2003). The
unique pharmacological profile of l-THP distinguishes it from other DA
antagonist drugs and may make it a more suitable medication for
treating cocaine addiction.
We and others have recently demonstrated that l-THP
attenuates cocaine self-administration (SA; Mantsch et al., 2007; Xi et
al., 2007), cocaine-evoked reinstatement (Mantsch et al., 2007),
cocaine discrimination (Mantsch et al., 2010) and cocaine-induced
reductions in intra-cranial self-stimulation (ICSS) thresholds (Xi et al.,
2007) in rats at doses that produce little or no impairment of motor
function. Along with the findings of a recent preliminary clinical trial
demonstrating that l-THP attenuates craving and relapse in recovering
heroin addicts (Yang et al., 2008), these data suggest that further
investigation of the utility of l-THP for the treatment of cocaine
addiction is warranted.
In the present study we investigated the ability of l-THP isolated
from the roots of Stephania delavayi Diels (Di Bu Long) acquired from
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Yunnan province in China, when administered orally by gavage, to
block reinstatement of extinguished drug-seeking behavior by drug reexposure, stress, and the presentation of drug-associated cues. In an
attempt to further dissociate l-THP’s effects on reinstatement from its
sedative/motor effects, we also examined the effects of orally
administered l-THP on food-reinforced lever pressing in a separate
group of rats and on baseline lever pressing following extinction.

2. Methods
2.1. Drugs
Cocaine hydrochloride was obtained through the National
Institute on Drug Abuse Drug Supply Program and was dissolved in
0.9% NaCl. l-THP, isolated from the crushed and dried tuberous roots
of Stephania delavayi Diels (Di Bu Long) grown in Yunnan province in
China, was acquired from Guangxi Nanning Baihui Pharmaceutical
Group (Nanning, Guangxi, China) via the Beijing Basic Science
Research Institute (Beijing, China) and was dissolved in sterile water.
The purity of the isolated l-THP, according to the manufacturer, was
greater than 99% as determined using high performance liquid
chromatography.

2.2. Subjects
A total of 44 adult male Sprague-Dawley rats (Harlan
Laboratories, St. Louis, MO) weighing 325g – 350g at the start of the
study were used. Rats were housed individually in a temperature- and
humidity-controlled environment in an AAALAC-accredited animal
facility under a 12 h/12 h reversed light/dark cycle (testing during the
dark cycle). Availability of food was restricted to 20-25 g each day, a
condition that maintains body weight at approximately 80-85% of
free-feeding levels, in order to facilitate the acquisition of SA (De Vry
et al., 1989). Notably, it has been reported that this level of chronic
food restriction does not alter the reinstatement of extinguished
cocaine-seeking behavior by cocaine, stress, or cocaine-assocaiated
cues (Bongiovanni and See, 2008). Water was available at all times
during the study, including in the SA chambers. All procedures were
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carried out in accordance with the Guide for the Care and Use of
Animals as adopted and promulgated by the NIH.

2.3. Catheterization Surgery
Rats were implanted with indwelling jugular catheters attached
to a back-mounted guide cannula under ketamine (100 mg/kg, ip) and
xylazine (2 mg/kg, ip) anesthesia and were allowed to recover for five
days before SA, during which time they were provided acetaminophen
(480 mg/l) in their drinking water. After implantation, rats were
injected daily with an antibiotic, cefazolin (15 mg, iv). For SA, a
polyurethane delivery line encased in a stainless-steel leash was
connected to the cannula to permit infusion of drug from a 30-ml
syringe mounted in a motor-driven syringe pump via a leak-proof
swivel suspended above the chamber. The swivel-and-leash assembly
was counterbalanced to permit relatively unrestrained movement
within the chamber. Catheters were filled daily with heparin (83 IU/ml)
and capped when the delivery line was disconnected.

2.4. Effects of l-THP on cocaine- and EFS-induced
reinstatement
Fifteen total rats were tested for the effects of oral pretreatment
with l-THP on reinstatement induced by cocaine (10 mg/kg) and a
stressor, uncontrollable intermittent electric footshock (EFS).

2.4.1. Cocaine SA
Rats were initially trained to self-administer cocaine (1.0
mg/kg/inf, iv) by pressing a lever under a fixed-ratio one (FR1)
schedule during daily 2-h sessions, within which the active (i.e., front)
lever was extended into the chamber and the corresponding stimulus
light was illuminated. Pressing this lever resulted in an iv infusion of
cocaine solution (200μl delivered over 5.0 s) followed by a 25-s timeout period during which the stimulus light was extinguished but the
lever remained extended. Responding on the second, inactive (i.e.,
back) lever was recorded but had no programmed consequences. Once
stable and significant SA under the FR1 schedule was observed (i.e., >
10 infusions), the response requirements for SA were gradually
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increased to FR4. Once a stable response pattern was observed under
the FR4 schedule (total responding < 10% variation from the mean
over 3 consecutive sessions), rats were provided daily 6-h access to
cocaine for SA under the FR4 schedule for 14 consecutive sessions
prior to extinction. We have found that later reinstatement by cocaine
or EFS is most pronounced following SA under these conditions
(Mantsch et al., 2004; Mantsch et al., 2008).

2.4.2. Extinction
Extinction conditions were identical to those during SA, except
that the extinction sessions only lasted for two hours and the cocaine
solution was replaced with saline. Rats were tested daily for extinction
until they emitted less than 15 responses during an extinction session
or until they displayed stable patterns of low-level (<25
responses/session) responding over two consecutive sessions, at
which time they were tested for reinstatement.

2.4.3. Cocaine- and EFS-Induced Reinstatement
Each rat was tested twice for reinstatement following ip
administration of 10 mg/kg cocaine and twice for reinstatement
following EFS (four tests total: once following vehicle pretreatment and
once following l-THP pretreatment for each stimulus). Separate groups
of rats were used to test the effects of 3 mg/kg l-THP and 10 mg/kg lTHP on reinstatement. We have found that prior testing for EFSinduced reinstatement fails to alter subsequent cocaine-induced
reinstatement and vice versa. Nonetheless, we counterbalanced the
sequence of cocaine- and EFS-induced reinstatement testing such that
half of the subjects received cocaine first and the other half received
EFS first. Likewise, the sequence of vehicle and l-THP pretreatment
was counterbalanced for each reinstating stimulus. Reinstatement
sessions were identical to extinction sessions except that they were
preceded by an ip cocaine injection or EFS and a pretreatment with lTHP or vehicle. Cocaine-induced reinstatement testing consisted of ip
administration of 10 mg/kg cocaine immediately prior to placing the
rats into the chambers for the 2-h reinstatement session. EFS-induced
reinstatement consisted of intermittent uncontrollable shocks through
stainless steel grid floors of the SA/extinction/reinstatement test
chambers for 10 minutes immediately prior to the 2-h reinstatement
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session. Shocks (0.5 mA, 0.5 s duration) were delivered on an average
of every 40 s (range 10 – 70) during the 10-min period within which
the house light was on, both response levers were retracted and the
stimulus lights were extinguished. Rats were treated with l-THP or
vehicle by oral gavage one hr prior to each reinstatement test session.
Reinstatement test sessions were separated by additional extinction
training. Rats were required to exhibit responding within 10% of
earlier extinction levels before the next reinstatement test.

2.5. Cue-Induced Reinstatement
A total of 20 rats were assigned to the cue-induced
reinstatement experiment. For this experiment, rats were tested under
SA, extinction, and reinstatement conditions similar to those
previously reported (Meil and See, 1996; See et al., 2001) with the
exception that cocaine during the SA sessions and response-contingent
cues during the reinstatement sessions were delivered under a FR4
schedule of reinforcement.

2.5.1. Cocaine SA
For these rats, cocaine SA training and testing were similar to
the conditions described above except that: 1) SA sessions during the
test phase only lasted two hours, 2) the stimulus light above the
cocaine lever was extinguished at the start of the session and 3) each
cocaine infusion self-administered under the FR4 schedule was paired
with the concurrent presentation of a 5-s auditory/visual compound
stimulus consisting of illumination of the stimulus light above the drug
lever and a 78 dB, 2 kHz tone. After the SA training criteria were
reached, rats were tested for SA under these conditions for an
additional 14 days prior to extinction training.

2.5.2. Extinction
For these rats, extinction sessions were identical to the SA
sessions except that lever pressing produced no consequences (i.e., no
infusions or compound stimulus presentation). As described in Section
2.4.2., rats were tested daily for extinction until they emitted less than
15 responses during an extinction session or until they displayed
stable patterns of low-level (<25 responses/session) responding over
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two consecutive sessions at which time they were tested for
reinstatement.

2.5.3. Reinstatement
Each rat was tested twice for cue-induced reinstatement (once
following vehicle pretreatment and once following l-THP pretreatment
for each stimulus). Half of the rats were tested first for reinstatement
following administration of oral l-THP. The remaining rats were tested
first for reinstatement following vehicle administration. Separate
groups of rats were used to test the effects of 3 mg/kg l-THP and 10
mg/kg l-THP on reinstatement. Reinstatement conditions were
identical to those during extinction, except that responses on the
previously active lever resulted in 5-sec presentations of the cocainepaired light-tone stimulus complex in the absence of cocaine
reinforcement. Rats were treated with l-THP or vehicle by oral gavage
one hr prior to each reinstatement test session. Reinstatement test
sessions were separated by additional extinction training as described
in section 2.4.3.

2.6. Effects of l-THP on Baseline Post-Extinction
Responding
Since we did not design our reinstatement experiments to
determine if l-THP altered lever pressing in the absence of a
reinstating stimulus, nine rats were tested for the effects of oral l-THP
(3 and 10 mg/kg) and vehicle on baseline responding following
extinction. These rats were randomly selected from the rats used to
determine the effects of l-THP on cocaine- and EFS-induced
reinstatement and were tested under the extinction conditions
described above (Section 2.4.2.) after reinstatement testing was
complete. Each rat was tested for the effects of l-THP (3 and 10
mg/kg) or vehicle administered orally one hour prior to the extinction
session in counterbalanced sequence. Rats were required to display
stable patterns of responding prior to testing (total responding < 10%
variation from the mean over 3 consecutive sessions) and were
required to exhibit responding within 10% of the earlier 3-day mean
before the next test.
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2.7. Effects of l-THP on Food-Reinforced Responding
To further examine the potential role of sedation-related motor
impairment in the effects of l-THP on reinstatement, the effects of oral
l-THP administration (0, 3, and 10 mg/kg) on food-reinforced lever
pressing was examined in a separate group of rats trained to selfadminister 45 mg sucrose-sweetened food pellets (Noyes Precision
Pellets, Formula F; Research Diets, New Brunswick, NJ) under an FR4
schedule of reinforcement during daily 30-min sessions. Food
availability was indicated by illumination of a stimulus light above the
lever. Once stable patterns of lever pressing were observed (total
responding < 10% variation from the mean over 3 consecutive
sessions), rats were tested for the effects of oral l-THP (3 or 10
mg/kg) or vehicle, administered one hr before a food session, on
responding. Each rat was tested with each l-THP dose and vehicle in
counterbalanced sequence. Rats were required to display stable
response patterns (within 10% of the earlier 3-day mean) prior to
testing with the next l-THP dose or vehicle.

2.8. Statistical Analyses
All statistical analyses were conducted using PASW (Predictive
Analytics SoftWare) statistics software (SPSS, Inc.). The effects l-THP
on reinstatement by each of the three stimuli (cocaine, stress and
cues) were initially examined using 3-way (reinstatement × l-THP
treatment × l-THP dose) ANOVA with reinstatement and l-THP
treatment as within subjects measures and dose as a between
subjects measure. These analyses were followed by 2-way
(reinstatement × l-THP) repeated measures ANOVA at each l-THP dose
for each stimulus. Post-hoc testing consisted of Bonferroni-corrected ttests. One-way ANOVA (vehicle, 3 and 10 mg/kg l-THP) followed by
post-hoc testing using Bonferroni-corrected t-tests was used to
examine the effects of l-THP on baseline post-extinction and foodreinforced responding. For all analyses, significance was defined as P
<0.05.

Drug and Alcohol Dependence, Vol. 116, No. 1-3 (July 2011): pg. 72-79. DOI. This article is © Elsevier and permission has
been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

10

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

3. Results
3.1 Cocaine SA and Extinction
Five of the 35 total rats used for the SA/reinstatement
experiments did not complete the study due to catheter failure, illness
or death. The mean numbers of training sessions prior to the
acquisition of SA and extinction sessions prior to the first
reinstatement test for each group are shown in Table 1.

3.2 Cocaine-induced reinstatement
Seven rats were tested for the effects of 3 mg/kg l-THP and six
rats were tested for the effects of 10 mg/kg l-THP on cocaine-induced
reinstatement (Figure 1). A 3-way ANOVA was used to examine
cocaine-induced reinstatement (cocaine vs. extinction; repeated
measure) following pretreatment with vehicle or l-THP (repeated
measure), at two oral l-THP doses (3 mg/kg and 10 mg/kg; between
subjects measure). Significant main effects of cocaine administration
(F1,11=13.611; P<0.01), and l-THP treatment (F1,11=13.001; P<0.01)
but not l-THP dose (P=0.932) were observed, as was a significant
interaction between l-THP treatment and cocaine-induced
reinstatement (F1,11=;14.007; P<0.01). Significant l-THP dose ×
reinstatement or l-THP treatment × dose × reinstatement interactions
were not observed.
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Figure 1

l-THP attenuates cocaine-induced reinstatement. Data represent

responses on the cocaine lever during the final 6-h cocaine SA session (SA), the 2-h
extinction session prior to reinstatement testing (Ext), and the 2-h reinstatement test
session prior to which a 10 mg/kg (ip) injection of cocaine (Coc) was administered in
rats tested for reinstatement following oral delivery of vehicle or 3 mg/kg (1A; n=7) or
10 mg/kg (1B; n=6) l-THP. Cocaine-induced reinstatement was observed following
vehicle but not l-THP pretreatment (*P<0.05 vs. Ext) and l-THP pretreated rats
displayed significantly less cocaine-induced reinstatement compared to Veh controls
(#P<0.05 vs. Veh).

To further examine the effects of l-THP on cocaine-induced
reinstatement, 2-way cocaine reinstatement × l-THP pretreatment
ANOVAs were used for each dose group. In rats pretreated with the 3
mg/kg l-THP dose (Figure 1A), significant main effects of both cocaine
administration (F1,6=6.621; P<0.05) and l-THP treatment
(F1,6=10.354; P<0.05) were observed, as was an l-THP × cocaine
reinstatement interaction (F1,6=6.316; P<0.05). Post-hoc testing
revealed that significant cocaine-induced reinstatement was observed
in vehicle but not 3 mg/kg l-THP treated rats and was significantly
reduced in rats pretreated with 3 mg/kg l-THP compared to rats
pretreated with vehicle (P<0.05). In rats pretreated with the 10 mg/kg
l-THP dose (Figure 1B), a significant main effect of cocaine
administration (F1,5=8.188; P<0.05) but not 10 mg/kg l-THP treatment
(P=0.106) was observed, as was a 10 mg/kg l-THP × cocaine
reinstatement interaction (F1,5=11.443; P<0.05). Once again, post-hoc
testing showed that significant cocaine-induced reinstatement was
observed in vehicle but not 10 mg/kg l-THP treated rats and was
Drug and Alcohol Dependence, Vol. 116, No. 1-3 (July 2011): pg. 72-79. DOI. This article is © Elsevier and permission has
been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

12

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

significantly reduced in rats pretreated with 10 mg/kg l-THP compared
to rats pretreated with vehicle (P<0.05).

3.3 Stress-induced reinstatement
Seven rats were tested for the effects of 3 mg/kg l-THP and six
rats were tested for the effects of 10 mg/kg l-THP on stress- (EFS-)
induced reinstatement (Figure 2). A 3-way ANOVA was used to
examine stress-induced reinstatement (EFS vs. extinction; repeated
measure) following pre-treatment with vehicle or l-THP (repeated
measure), at two l-THP doses (3 mg/kg and 10 mg/kg; between
subjects measure). Significant overall main effects of stress
(F1,11=11.171; P<0.01), and l-THP treatment (F1,11=9.552; P=0.01)
but not l-THP dose (P=0.932) were observed, as was a significant
interaction between l-THP treatment and stress-induced reinstatement
(F1,11=11.442; P<0.01). Significant l-THP dose × reinstatement or lTHP treatment × dose × reinstatement interactions were not
observed.

Figure 2

l-THP attenuates the reinstatement of extinguished cocaine seeking by a

stressor, uncontrollable electric footshock (EFS), delivered intermittently prior to the
test session. Data represent responses on the cocaine lever during the final 6-h
cocaine SA session (SA), the 2-h extinction session prior to reinstatement testing
(Ext), and the 2-h reinstatement test session (EFS) in rats tested for reinstatement
following oral administration of vehicle or 3 mg/kg (2A; n=7) or 10 mg/kg (2B; n=6)
l-THP. EFS reinstated cocaine seeking following vehicle but not l-THP pretreatment
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(*P<0.05 vs. Ext) and l-THP pretreated rats displayed significantly less EFS-induced
cocaine seeking compared to Veh controls (#P<0.05 vs. Veh).

To more closely examine the effects of l-THP on stress-induced
reinstatement, 2-way stress-induced reinstatement × l-THP
pretreatment ANOVAs were used for each dose group. In rats
pretreated with the 3 mg/kg l-THP dose (Figure 2A), significant main
effects of both stress (F1,6=10.338; P<0.05) and 3 mg/kg l-THP
treatment (F1,6=12.946; P<0.05) were observed, as was a 3 mg/kg lTHP × stress-induced reinstatement interaction (F1,6=7.396; P<0.05).
Post-hoc testing revealed that significant EFS-induced reinstatement
was observed in vehicle but not 3 mg/kg l-THP treated rats and that
stress-induced reinstatement was significantly reduced in rats
pretreated with 3 mg/kg l-THP compared to rats pretreated with
vehicle (P<0.05). In rats pretreated with the 10 mg/kg l-THP dose
(Figure 2B), a significant 10 mg/kg l-THP × stress-induced
reinstatement interaction (F1,5=7.545; P<0.05) but no significant main
effect of EFS or 10 mg/kg l-THP treatment was observed. Once again,
post-hoc testing showed that significant stress-induced reinstatement
was observed in vehicle but not 10 mg/kg l-THP treated rats and that
stress-induced reinstatement was significantly reduced in rats
pretreated with 10 mg/kg l-THP compared to rats pretreated with
vehicle (P<0.05).

3.4 Cue-induced reinstatement
Ten rats were tested for the effects of 3 mg/kg l-THP and seven
rats were tested for the effects of 10 mg/kg l-THP on cue-induced
reinstatement (Figure 3). A 3-way ANOVA was used to examine cueinduced reinstatement (cue vs. extinction; repeated measure)
following pre-treatment with vehicle or l-THP (repeated measure), at
two l-THP doses (3 mg/kg and 10 mg/kg; between subjects measure).
Significant main effects of cue presentation (F1,15=11.512; P<0.01),
and l-THP treatment (F1,15=14.983; P<0.01) but not l-THP dose
(P=0.247) were observed, as was a significant interaction between lTHP treatment and cue-induced reinstatement
(F1,15=20.674;P<0.001). Significant l-THP dose × cue reinstatement or
l-THP treatment × dose × cue reinstatement interactions were not
observed.
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Figure 3

l-THP prevents the reinstatement of extinguished cocaine seeking by

response contingent presentation of cues (tone-light complex) previously associated
with cocaine SA. Data represent responses on the cocaine lever during the final 2-h
cocaine SA session (SA), the 2-h extinction session prior to reinstatement testing
(Ext), and the 2-h reinstatement test session (Cue) in rats tested for reinstatement
following oral administration of vehicle or 3 mg/kg (3A; n=10) or 10 mg/kg (3B; n=7)
l-THP. Cue presentation reinstated cocaine seeking following vehicle but not l-THP
pretreatment (*P<0.05 vs. Ext) and l-THP pretreated rats displayed significantly less
cue-induced cocaine seeking compared to Veh controls (#P<0.05 vs. Veh).

As described above, to further examine the effects of l-THP on
cue-induced reinstatement, 2-way cue-induced reinstatement × l-THP
pretreatment ANOVAs were used for each dose group. In rats
pretreated with the 3 mg/kg l-THP dose (Figure 3A), significant main
effects of both cue presentation (F1,9=11.144; P<0.01) and l-THP
treatment (F1,9=8.433; P<0.05) were observed, as was an l-THP × cue
presentation interaction (F1,9=10.968; P<0.01). Post-hoc testing
revealed that significant cue-induced reinstatement was observed in
vehicle but not l-THP treated rats and was significantly reduced in rats
pretreated with l-THP compared to rats pretreated with vehicle
(P<0.05). In rats pretreated with the 10 mg/kg l-THP dose (Figure
3B), significant main effects of cue presentation (F1,6=6.559; P<0.05)
but not 10 mg/kg l-THP treatment (P=0.156) were observed, as was a
10 mg/kg l-THP × cue presentation interaction (F1,6=9.176; P<0.05).
Post-hoc testing revealed that significant cue-induced reinstatement
was observed in vehicle but not 10 mg/kg l-THP treated rats and was
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significantly reduced in rats pretreated with 10 mg/kg l-THP compared
to rats pretreated with vehicle (P<0.05).

3.5 Effects on baseline post-extinction responding
Since our original reinstatement design did not include testing
for the effects of l-THP on baseline extinction responding, an additional
nine rats were tested for the effects of 3 and 10 mg/kg l-THP on
responding during an extinction session in order to determine if l-THP
induced reductions in reinstatement may have been attributable to
non-specific impairment of the ability of the rats to press the lever
(Figure 4). Although one-way repeated measures ANOVA failed to
show a significant effect of l-THP on responding (P=0.058), lever
pressing was markedly reduced in rats following administration of the
10 mg/kg l-THP dose. Post-hoc testing using Bonferroni-correct t-tests
revealed that responding after administration of 10 mg/kg l-THP was
significantly reduced compared to responding following administration
of 3 mg/kg l-THP (P<0.05) but not vehicle (P=0.173).

Figure 4

Effects of l-THP on baseline extinction responding. Lever pressing during

the 2-h session was significantly reduced by oral administration of 10 mg/kg l-THP
compared to 3 mg/kg l-THP but not vehicle (V; *P<0.05). No effects of 3 mg/kg l-THP
were found.
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3.6 Food-reinforced lever pressing
To further test if l-THP induced reductions in reinstatement may
have been attributable to non-specific motor impairment, the effects of
oral l-THP on food-reinforced lever pressing were examined in eight
rats trained to self-administer sucrose-sweetened food pellets under a
FR4 schedule of reinforcement and are shown in Figure 5. One-way
repeated measures ANOVA showed a significant effect of l-THP on
food-reinforced responding (F2,14=12.315; P=0.001). Post-hoc testing
using a Bonferroni-corrected t-test showed that responding was
significantly attenuated following oral administration of the 10 mg/kg,
but not 3 mg/kg, l-THP dose (P<0.05).

Figure 5

Effects of l-THP on food-reinforced lever pressing. Food- (sucrose-

sweetened pellet-) reinforced lever pressing under a FR4 schedule during 30 min
sessions was significantly reduced by oral administration of 10 mg/kg but not 3 mg/kg
l-THP (*P<0.001 vs. V).
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4. Discussion
4.1 Summary of findings
We and others have previously reported that ip administration
of l-THP attenuates cocaine SA under both FR and PR (progressive
ratio) schedules (Mantsch et al., 2007; Xi et al., 2007; Mantsch et al.,
2010), cocaine-induced reductions in ICSS thresholds (Xi et al., 2007),
cocaine discrimination (Mantsch et al., 2010) and cocaine-induced
reinstatement of extinguished cocaine-seeking behavior (Mantsch et
al., 2007). This paper extends these findings by demonstrating that lTHP, administered orally, also attenuates cocaine-induced
reinstatement, as well as reinstatement by a stressor (uncontrollable
EFS) or response-contingent delivery of conditioned cues previous
paired with cocaine SA. In each case, l-THP decreased reinstatement
at a dose (3 mg/kg) that failed to alter food-reinforced lever pressing
or baseline post-extinction responding, suggesting that l-THP-induced
decreases in cocaine seeking were likely not secondary to non-specific
motor impairment by l-THP.

4.2. l-THP as an anti-craving/anti-relapse agent
The sudden and often unpredictable relapse of drug use after
extended periods of abstinence continues to pose a major challenge to
the effective treatment of cocaine addiction. For this reason, the
identification and development of medications aimed at preventing
relapse through the targeting of neurobiological pathways that underlie
drug craving continues to be a high priority for addiction researchers
(O’Brien, 2005). Although the ability of the reinstatement approach to
predict effective anti-craving medications remains a matter of debate
(Epstein et al., 2006; Yahyavi-Firouz-Abadi and See, 2009), our
findings that l-THP, when administered orally, attenuates
reinstatement by cocaine re-exposure, presentation of drug-associated
cues, or stress, three of the primary precipitating factors of craving in
human addicts, while at the same time attenuating the reinforcing
effects of cocaine (Mantsch et al., 2007; Xi et al., 2007; Mantsch et
al., 2010), suggests that examination of the efficacy of l-THP in human
populations may be justified. Accordingly, a recent preliminary clinical
trial reported that l-THP reduces drug craving and relapse in
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recovering heroin addicts (Yang et al., 2008). Clinical testing of l-THP
effectiveness in the US awaits further examination of its safety for use
in humans.

4.3. Dopamine receptor antagonist properties of l-THP
It is likely that the effects of l-THP on cocaine-seeking behavior
are related to its antagonism of DA receptors. A large body of data,
including our own preliminary analyses, indicates that l-THP is an
antagonist at D1R and D2R (Jin, 1987; Guo et al., 1997; Mantsch et
al., 2007; Huang and Jin, 1992; Hu and Jin, 1999; Jin et al., 1986;
Sun et al., 1992; Wu et al., 1990; Xu et al., 1989; Zhu et al., 1991).
Considering the involvement of dopaminergic neurotransmission in
cocaine-seeking behavior (see Volkow et al., 2004; Anderson and
Pierce, 2005 for reviews), compounds such as l-THP that antagonize
DA receptors have long been thought to represent potential
medications for the management of cocaine addiction. Compared to
many other DA receptor antagonist drugs, l-THP has lower affinity for
D2R relative to D1R (Jin, 1987). l-THP also binds to D3 DA receptors
(Mantsch et al., 2007) at concentrations reached in the brain following
oral administration of the doses tested in this study (Hong et al.,
2006), likely functioning as an antagonist; an effect that may
contribute to its blockade of cocaine-mediated responses (Mantsch et
al., 2010). The blockade of pre-synaptic autoreceptors by l-THP results
in increased dopamine release (Marcenac et al., 1986) and it has been
suggested that lower affinity of l-THP for D2R may confer some degree
of autoreceptor selectivity (Jin et al., 1986).

4.4. Dopamine receptors and relapse
In addition to establishing l-THP as a potentially effective
medication for the management of relapse, the present data suggest
that DA may be a common mediator of relapse in response to stress,
cocaine re-exposure, and exposure to cocaine-associated cues. These
findings are consistent with a large body of literature implicating DA
receptors in reinstatement (see Volkow et al., 2004; Anderson and
Pierce, 2005 for reviews). DA receptor agonists (Khroyan et al., 2003;
de Vries et al., 1999) and selective DA transport blockers (Schmidt
and Pierce, 2006b; Schenk and Gettings, 2003) reinstate extinguished
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cocaine seeking, while systemic administration of DA antagonists and
low-efficacy agonists at D1, D2, and D3 DA receptors (D1R, D2R, and
D3R) have been reported to attenuate drug seeking evoked by cocaine
re-exposure (Khroyan et al., 2003: D1R; Khroyan et al., 2000: D1R
and D2R; Schenk and Gettings, 2003: D2R; Vorel et al., 2002: D3R; Xi
et al., 2005: D3R; Peng et al., 2009: D3R), presentation of cocaineassociated cues (Ciccocioppo et al., 2001: D1R; Alleweireldt et al.,
2002: D1R; Feltenstein et al., 2007: D2R; Crombag et al., 2002: D1R
and D2R; Cervo et al., 2003: D2/3R; Cervo et al., 2007:D3R; Di Ciano
et al., 2003: D3R; Gilbert et al., 2005: D3R), and stress (Xi et al.,
2004; D3R).
While DA may be involved in reinstatement in response to each
of these stimuli, the neuroanatomical site of DA action appears to
vary, depending on the reinstating stimulus. For example, DA
activation of D1R in the amygdala, particularly the basolateral
amygdala appears to play a critical role in cue-induced reinstatement
(See et al., 2001; Alleweireldt et al., 2006), while prefrontal cortical
D1R activation appears to be important for stress-induced
reinstatement (McFarland et al., 2003; Capriles et al., 2003; Sanchez
et al., 2003), and D1R and D2R activation in the nucleus accumbens
shell (Anderson et al., 2003; 2006; Bachtell et al., 2005; Schmidt et
al., 2006a; Schmidt and Pierce, 2006) as well as D1R activation in
prefrontal cortical regions (McFarland et al., 2001; Sun and Rebec,
2005) appears to be required for reinstatement in response to cocaine.
Notably, high levels of cocaine intake such as those reached during the
6-h sessions used for the rats tested for cocaine- and stress-induced
reinstatement in the present study and often observed in cocaine
addicts appears to recruit DA involvement in drug seeking in additional
brain regions, such as the NA core (Madayag et al., 2010), further
establishing the importance of the DA system as a target for
pharmacotherapy.

4.5. Effects of l-THP at non-DA receptors
Our own preliminary binding analysis suggests that l-THP, at
brain concentrations comparable to those that may be reached
following oral l-THP delivery (Hong et al., 2006) also displays
moderate binding to alpha-1 and alpha-2 adrenergic receptors as well
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as strong binding to 5-HT1A receptors (Mantsch et al., 2007 and
unpublished findings). l-THP is an antagonist at alpha-1 adrenergic
receptors (Lu et al., 1996). The effects at alpha-2 adrenergic receptors
are unclear; l-THP has been reported to both mimic (Wu and Jin,
1995) and block (Liu et al., 1989) the effects of the alpha-2 adrenergic
receptor agonist, clonidine. The actions of l-THP at 5-HT1A receptors
(i.e., full agonist, partial agonist, vs. antagonist) have not been
reported. It has also been found that l-THP has positive cooperative
effects at the GABAA receptor (Halbsguth et al., 1996), an effect that
may contribute to the high-dose behavioral suppressive effects of lTHP (Xu et al., 1981). Despite its use as an analgesic, no interaction of
l-THP with opioid receptors has been reported, and it analgesic effects
are naloxone-independent (Hu and Jin, 1999).
These interactions of l-THP with non-DA receptors, most notably
its likely antagonism of alpha-1 adrenergic receptors and interaction
with 5-HT1A receptors, may also contribute to its effects on cocaine
seeking behavior and could mitigate some of the undesirable effects
associated with DA receptor antagonism, thus further distinguishing lTHP from other DA receptor antagonist drugs. Alpha-1 adrenergic
(Zhang and Kosten, 2005) and 5-HT1A (Burmeister et al., 2004)
receptor antagonists have been previously reported to attenuate
cocaine seeking in rats. Secondary actions of l-THP at 5-HT1A and
alpha adrenergic receptors could also minimize the extrapyramidal
effects associated with DA receptor antagonism by l-THP (Imaki et al.,
2009; Kalkman et al., 1998; Millan et al., 2000; Wadenberg, 1996).

4.6. Sedative effects of l-THP
The effectiveness of DA antagonists for the treatment of cocaine
addiction has been limited by problematic side effects, including motor
impairment/sedation and anhedonia, attributable in part to undesirable
pharmacological profiles (Platt et al., 2002). Additionally, the primary
clinical feature of overdose intoxication with l-THP-containing
preparations (which also typically contain a number of other
pharmacologically active constituents) is central nervous system
depression (Horowitz et al., 1996). To ensure that motor impairment
did not contribute to the observed effects on reinstatement and to
demonstrate dose separation between the toxic and therapeutic effects
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of l-THP, we tested rats for non-specific motor impairment at the same
doses used for reinstatement testing. Consistent with previous findings
with ip l-THP (Mantsch et al., 2007; Xi et al., 2007), we found that,
although l-THP produced dose-dependent motor impairment, as
demonstrated by reductions in baseline extinction and food-reinforced
responding, effects on reinstatement were observed at an l-THP dose
(i.e., 3 mg/kg) that had no effects on lever-pressing during the food or
extinction sessions.
Although we assume that the behavioral suppression observed
at the higher (i.e., 10 mg/kg) l-THP dose was primarily attributable to
high-dose sedative effects, it is possible that aversive effects may
have also contributed. l-THP, at higher doses, has been reported to
increase thresholds for ICSS (Xi et al., 2007) and to reduce the
breaking point for non-drug (sucrose sweetened) reinforcement under
a progressive ratio schedule (Mantsch et al., 2010). However, in both
cases, these effects, which potentially reflect anhedonia, emerged at
doses higher than those at which effects on responses to cocaine were
observed and may have been related to motor impairment. Further, lTHP, at doses as high as 18.5 mg/kg (ip), does not produce
conditioned place aversion (Liu et al., 2009) and anxiogenic effects of
l-THP have not been reported. In fact, racemic (dl) THP has been
reported to have anxiolytic properties (Leung et al., 2003) and l-THP
containing preparations are often used for their sedative effects. Thus,
we consider it to be unlikely that the general disruption of behavior
observed at the higher l-THP dose was due to anxiogenic effects.
Although approved for use in China, further preclinical and
clinical examination of l-THP is needed to determine if it is safe enough
for the US market and to distinguish from other DA antagonist drugs.

4.7. Conclusions
To summarize, orally administered l-THP was effective in
preventing reinstatement by three different stimuli in a rat model of
drug relapse at doses that did not produce measurable motor
impairment. These findings add to a growing body of evidence
suggesting that l-THP and other similar compounds derived from
natural sources may themselves have medicinal value and/or may
provide insight into desirable pharmacological profiles for future
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medications. Although additional determination of the efficacy and
safety of l-THP in human populations is necessary, our findings
suggest that l-THP or l-THP containing preparations may have utility
for facilitating relapse prevention and for the treatment of cocaine
addiction.
Footnotes
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